Friends & Shareholders,
In July, I was invited to Washington, D.C. to record an interview with Emmy Award-winning journalist Sharyl Attkisson for her nationally syndicated program, Full Measure. We had no idea when it would air, let alone considered that it would become a cover story for such a major program.
Full Measure reaches 43 million households in 79 markets across America.
The segment shares our journey from the garage floor to the Nasdaq floor. It also talks about Turn Therapeutics’ mission to help millions with a technology that began for one patient: me. Even more surprising, Sharyl followed it up with a feature episode on her podcast, expanding the reach even further.
You can watch and listen here:
🎥 Watch the Full Measure segment »
🎧 Listen to the After Hours podcast »
Receiving this level of national attention is a powerful moment for our company, our mission, and everyone who has believed in Turn from the beginning.
Bradley Burnam
Founder & CEO, Turn Therapeutics
